🇺🇸 FDA
Patent

US 12377252

Implantation devices, system, and methods

granted A61KA61K35/00

Quick answer

US patent 12377252 (Implantation devices, system, and methods) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K35/00